Mirum Pharmaceuticals (MIRM) Current Assets (2018 - 2026)

Mirum Pharmaceuticals' Current Assets history runs 9 years deep, the most recent figure standing at $569.4 million for Q1 2026.

• In Q1 2026, Current Assets rose 38.61% year-over-year to $569.4 million; the TTM figure through Mar 2026 stood at $569.4 million (up 38.61% YoY), while the FY2025 annual figure was $549.7 million, up 39.94% from the prior year.
• Current Assets for Q1 2026 stood at $569.4 million, up from $549.7 million in the prior quarter.
• The five-year high for Current Assets was $569.4 million in Q1 2026, with the low at $147.2 million in Q2 2022.
• The 5-year median for Current Assets is $387.5 million (2023), against an average of $358.3 million.
• The sharpest annual moves came in 2022 and 2023: Current Assets tumbled 35.52% in 2022, then surged 160.46% in 2023.
• Mirum Pharmaceuticals' Current Assets stood at $190.2 million in 2022, then jumped by 103.73% to $387.5 million in 2023, then increased by 1.35% to $392.8 million in 2024, then soared by 39.94% to $549.7 million in 2025, then increased by 3.59% to $569.4 million in 2026.
• Business Quant data shows MIRM's Current Assets at $569.4 million in Q1 2026, $549.7 million in Q4 2025, and $530.6 million in Q3 2025.